Acino

M.D., University of Tartu, Estonia
Degree in Economics, University of Tartu, Estonia

Chief Executive Officer and Member of Group Management since April 19, 2016

Business Economics, Norwegian School of Management BI, Sandvika, Norway

CFO Acino Group and Member of Group Management since April, 2014

Degree from the Geological Academy of Russian Federation, Moscow, Russia

Head of Corporate Business Development and Member of Group Management since May 16, 2014

Pharmaceutical doctor from the University of Clermont-Ferrand and Post Graduate Diploma in Pharmacology, Drug Development and Regulation from the Tuft Medical School in Boston, USA.

Head of Global Medical Affairs, Regulatory Affairs and Pharmacovigilance and Member of Group Management since August, 2016

German qualified lawyer, University of Passau, Passau, Germany

Chief Legal & Compliance Officer and Member of Group Management from March 16, 2015

PhD in Pharmaceutical Chemistry, Kiel University, Germany
MBA, WHU Koblenz, Germany, and Northwestern University of Chicago (Kellogg), USA

Chief Operations Officer and Member of Group Management since August 18, 2014

Masters Degree in Strategic Human Resources Management, Coventry Business School and Post Graduate Diploma from Croydon Business School, UK

Chief Human Resources Officer and Member of Group Management since May, 2016

Ph.D. in Neuroscience, Karolinska Institutet, Sweden

• Chairman of the Board of Acino Holding AG since December 17, 2013
• Current term of office on the Board expires in 2016

Håkan Björklund joined Avista Capital Partners in October 2011. Mr. Björklund is the former Chief Executive Officer of Nycomed, which was sold to Takeda Pharmaceuticals in September 2011. Under Mr. Björklund’s leadership, Nycomed grew from a predominantly Scandinavian business into a global pharmaceutical company with leading market positions in Europe, Russia/CIS, Brazil and Latin America. Prior to Nycomed, Mr. Björklund was Regional Director at Astra (now AstraZeneca) and, earlier, President of Astra Draco. He is Chairman of the Board of Directors at Lundbeck A/S, a member of the Board of Directors of Alere Inc., Coloplast A/S and Atos Medical AB. He was also a director at Danisco A/S until its recent acquisition by Dupont.

B.Sc. in Economics and Business Administration, University of Uppsala, Sweden

MBA, University of Wisconsin, USA

• Vice-Chairman of the Board of Acino Holding AG since December 17, 2013
• Current term of office expires in 2016

Toni Weitzberg joined NC Advisory AB, advisor to the Nordic Capital funds, in 2000. Prior to joining, Mr. Weitzberg held various executive positions within the Pharmacia Group, most recently as Senior Vice President and Head of Pharmacia Europe. He currently serves as a board member of Convatec and Handicare. Mr. Weitzberg is the former Chairman of Dynal, Biovitrum, Atos, Nycomed, as well as a former board member of Fougera Pharmaceuticals, Unomedical and Permobil.

M.Sc. in Finance and International Business, Stockholm School of Economics, Sweden

• Member of the Board of Acino Holding AG since
  December 17, 2013
• Current term of office expires in 2016

Jonas Agnblad joined NC Advisory AB, advisor to the Nordic Capital funds, in 2000. From 1999 to 2000, Mr. Agnblad worked in the corporate finance department at Warburg Dillon Read in London. He was previously a board member of Nycomed and Fougera Pharmaceuticals and is currently a board member of The Binding Site. Mr. Agnblad is based in Stockholm and focuses on the healthcare sector.

BA, University of Virginia, USA

MBA, Harvard Business School, USA

• Member of the Board of Acino Holding AG since
  December 17, 2013
• Current term of office expires in 2016

Tom Dean is the Co-Managing Partner and Co-CEO of Avista Capital Partners. Prior to co-founding Avista Capital Partners in 2005, Mr. Dean led DLJ Merchant Banking Partners (“DLJMB”), serving as Co-Managing Partner of DLJMB since 1995 and Chairman of the Investment Committees of DLJMB I, DLJMB II, DLJMB III and DLJ Growth Capital Partners through December 2007. Mr. Dean currently serves on the boards of ConvaTec, Sidewinder Drilling, Zest Anchors, and VWR International. Mr. Dean formerly served as the Chairman of the board of Nycomed, Arcade, DeCrane Aircraft, Mueller and Von Hoffmann. He also formerly served on the boards of American Ref-Fuel, Argyle Television, BioPartners, Charles River Labs, Evergreen Media, Merrill, Safilo, Visant and IWCO Direct Holdings, among others.

Master of Science (M.S.), Business Administration and Management, and Diploma degree, Finance, Copenhagen Business School, Denmark

• Member of the Board of Acino Holding AG since April 16, 2015
• Current term of office expires in 2016

Per Edelmann has been a corporate officer in the Specialty Pharma industry for more than 20 years in various companies and capacities. Most recently, he was Senior Vice President in Mylan Inc. responsible for Mylan Global Commercial Affairs, after having been Head of Teva Europe Commercial activities from 2006 to 2010. Per Edelmann was also part of the Actavis Group as Chief Executive International for the Nordic region, CIS/Russia, C&E Europe and Balkan. Since 2013 Per Edelmann acts as an Industry advisor and board member to private equity and pharma companies as well as being an advisor to the pharma investment community.

M.A. and B.A., Cambridge University, USA
MBA, Wharton School at the University of Pennsylvania, USA

• Member of the Board of Acino Holding AG since December 17, 2013
• Current term of office expires in 2016

Kunal Pandit joined Avista Capital Partners in 2010. Mr. Pandit was previously at DLJ Merchant Banking Partners (“DLJMB”) in London. Prior to DLJMB, Mr. Pandit was a member of the leveraged finance group and the investment banking department at Lehman Brothers in London. He currently serves as a director of Guala Closures.